Jubilant Ingrevia Limited has reported its Q3 financial performance, showing challenging results across key profitability metrics. The specialty chemicals and pharmaceutical intermediates company faced significant headwinds in maintaining both operational profitability and bottom-line performance during the quarter.

Financial Performance Overview

The company's Q3 consolidated results reveal substantial pressure on profitability metrics compared to the previous year. Both EBITDA and net profit declined significantly while revenue remained stable, indicating comprehensive margin compression during the reporting period.

EBITDA Performance Analysis

Jubilant Ingrevia's operational profitability came under significant pressure during Q3, with EBITDA declining to ₹1.3 billion from ₹1.8 billion in the corresponding quarter of the previous year. This 27.8% decrease reflects operational challenges faced by the company.

The EBITDA margin contracted to 12.04% from 13.1% year-on-year, representing a decline of 106 basis points. This margin compression indicates increased operational costs or pricing pressures impacting the company's core business operations.

Revenue and Profitability Trends

Despite maintaining revenue stability at ₹10.5 billion compared to ₹10.57 billion in the same quarter of the previous year, the company experienced significant profitability challenges. The marginal revenue decline of 0.7% contrasts sharply with the substantial drops in both EBITDA and net profit metrics.

The consolidated net profit fell to ₹469 million from ₹694 million year-on-year, representing a 32.4% decrease. The divergence between stable revenue and declining profitability metrics across both operational and net profit levels suggests comprehensive margin pressures affecting the specialty chemicals manufacturer during the quarter.

Jubilant Ingrevia Limited has announced an interim dividend of Rs.2.50 per equity share for the Financial Year 2025-26, marking a significant return to shareholders. The Board of Directors made this declaration during their meeting held on February 04, 2026.

Board Meeting and Dividend Declaration

The Board of Directors convened their meeting at 02:00 pm on February 04, 2026, which concluded at 05:15 pm. During this meeting, they declared the interim dividend on equity shares of Re. 1 each on the paid-up equity share capital of the company.

Record Date and Payment Schedule

In compliance with Regulation 42 of the SEBI Listing Regulations, the Board has established Tuesday, February 10, 2026 as the record date. This date will determine the eligibility of shareholders for receiving the interim dividend payment.

Regulatory Compliance

The dividend announcement was made in accordance with Regulations 30, 42 and 43 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has communicated this decision to both BSE Limited and National Stock Exchange of India Limited, where it trades under scrip code 543271 and trading symbol JUBLINGREA respectively.

Company Information

Jubilant Ingrevia Limited, part of the Jubilant Bhartia Group, operates from its registered office at Bhartiagram, Gajraula, Distt. Amroha, Uttar Pradesh. The company secretary Deepanjali Gulati signed the official communication digitally on February 04, 2026.